• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在蛋白质的情况下测量尿糖胺聚糖:一种基于二甲基亚甲基蓝的改进的黏多糖贮积症筛查方法。

Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

作者信息

de Jong J G, Wevers R A, Liebrand-van Sambeek R

机构信息

Laboratory of Paediatrics and Neurology, University Hospital Nijmegen, The Netherlands.

出版信息

Clin Chem. 1992 Jun;38(6):803-7.

PMID:1597005
Abstract

Earlier we described a simple and reliable screening procedure in urine for mucopolysaccharidoses based on the color reaction of glycosaminoglycans (GAGs) with dimethylmethylene blue. At physiological concentrations of urinary protein, we observed an obvious interference by protein in the assay. By modifying the assay, we abolished the protein interference. The modified procedure is not disturbed by human serum albumin, IgG (both tested with as much as 5 g/L of protein), or urinary proteins. The modified procedure appeared as reliable as the original. No false-negative results were found in a series of 26 urine samples from patients with mucopolysaccharidoses (sensitivity 100%). In a series of 405 urine samples offered for metabolic screening, 24 samples with increased GAG content and normal GAG composition were seen (specificity 94%). The method may also be applicable for determining GAG in other body fluids or solutions containing protein.

摘要

此前,我们描述了一种基于糖胺聚糖(GAGs)与二甲基亚甲蓝的颜色反应,用于尿液中黏多糖贮积症的简单可靠的筛查程序。在尿蛋白的生理浓度下,我们观察到蛋白质在该检测中产生明显干扰。通过对检测方法进行改进,我们消除了蛋白质干扰。改进后的程序不受人血清白蛋白、IgG(两者均以高达5 g/L的蛋白质进行测试)或尿蛋白的干扰。改进后的程序与原程序一样可靠。在一系列来自黏多糖贮积症患者的26份尿液样本中未发现假阴性结果(敏感性100%)。在提供用于代谢筛查的405份尿液样本中,发现24份样本的GAG含量增加且GAG组成正常(特异性94%)。该方法也可适用于测定其他体液或含蛋白质溶液中的GAG。

相似文献

1
Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.在存在蛋白质的情况下测量尿糖胺聚糖:一种基于二甲基亚甲基蓝的改进的黏多糖贮积症筛查方法。
Clin Chem. 1992 Jun;38(6):803-7.
2
Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.基于二甲苯亚甲基蓝的未处理尿液中糖胺聚糖分光光度法:黏多糖贮积症的快速筛查程序
Clin Chem. 1989 Jul;35(7):1472-7.
3
Screening for mucopolysaccharidoses in the Turkish population: Analytical and clinical performance of an age-range specific, dye-based, urinary glycosaminoglycan assay.在土耳其人群中进行黏多糖贮积症的筛查:一种年龄特异性、基于染料的尿糖胺聚糖检测的分析和临床性能。
Clin Chim Acta. 2017 Jan;464:72-78. doi: 10.1016/j.cca.2016.11.015. Epub 2016 Nov 15.
4
Neonatal screening for mucopolysaccharidoses by determination of glycosaminoglycans in the eluate of urine-impregnated paper: preliminary results of an improved DMB-based procedure.新生儿黏多糖贮积症的尿滤纸干片法酶联显色法定量检测:改良 DMB 法的初步结果。
J Clin Lab Anal. 2010;24(3):149-53. doi: 10.1002/jcla.20375.
5
Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests.通过二甲基亚甲基蓝和贝里斑点试验评估尿黏多糖贮积症筛查的可靠性。
Clin Chim Acta. 2004 Jul;345(1-2):135-40. doi: 10.1016/j.cccn.2004.03.015.
6
Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: an evaluation.使用亚甲蓝作为筛查技术定量检测尿糖胺聚糖以诊断黏多糖贮积症:一项评估
Ann Clin Biochem. 2007 Jul;44(Pt 4):360-3. doi: 10.1258/000456307780945688.
7
Usefulness of urinary glycosaminoglycans assay for a mucopolysaccharidosis-specific screening.尿糖胺聚糖检测在黏多糖贮积症特异性筛查中的应用。
Pediatr Int. 2020 Sep;62(9):1077-1085. doi: 10.1111/ped.14278.
8
Mucopolysaccharidoses screening: dimethylmethylene blue versus alcian blue.黏多糖贮积症筛查:二甲苯亚甲基蓝与阿尔辛蓝对比
Ann Clin Biochem. 1994 May;31 ( Pt 3):267-71. doi: 10.1177/000456329403100309.
9
The spot test is not a reliable screening procedure for mucopolysaccharidoses.斑点试验并非黏多糖贮积症可靠的筛查方法。
Clin Chem. 1991 Apr;37(4):572-5.
10
Interference of an algal nutritional supplement with a urinary metabolic screening test for glycosaminoglycans in a dog suspected to have a storage disease.一种藻类营养补充剂对疑似患有贮积病犬的糖胺聚糖尿液代谢筛查试验的干扰。
Vet Clin Pathol. 2013 Dec;42(4):504-7. doi: 10.1111/vcp.12096. Epub 2013 Oct 25.

引用本文的文献

1
College of American Pathologists (CAP)/American College of Medical Genetics and Genomics (ACMG) proficiency testing for urinary glycosaminoglycan analysis: A summary of performance.美国病理学家学会(CAP)/美国医学遗传学与基因组学学会(ACMG)尿糖胺聚糖分析能力验证:性能总结
Genet Med Open. 2024 Dec 14;3:101912. doi: 10.1016/j.gimo.2024.101912. eCollection 2025.
2
Profiling Bioactive Components of Natural Eggshell Membrane (NEM) for Cartilage Protection and Its Protective Effect on Oxidative Stress in Human Chondrocytes.分析天然蛋壳膜(NEM)的生物活性成分,用于软骨保护及其对人软骨细胞氧化应激的保护作用。
Int J Mol Sci. 2024 Oct 21;25(20):11304. doi: 10.3390/ijms252011304.
3
Optimization of Automated Dimethylmethylene Blue Assay for Quantification of Pediatric Urine Samples.
用于定量分析儿科尿液样本的自动二甲基亚甲基蓝检测法的优化
Indian J Clin Biochem. 2024 Oct;39(4):519-528. doi: 10.1007/s12291-023-01173-w. Epub 2023 Dec 18.
4
Specific GAG ratios in the diagnosis of mucopolysaccharidoses.特定糖胺聚糖比率在黏多糖贮积症诊断中的应用
JIMD Rep. 2024 Feb 8;65(2):116-123. doi: 10.1002/jmd2.12412. eCollection 2024 Mar.
5
Biochemical diagnosis of Sanfilippo disorder types A and B.A 型和 B 型桑菲利波综合征的生化诊断
J Genet Eng Biotechnol. 2023 Nov 10;21(1):112. doi: 10.1186/s43141-023-00586-7.
6
Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy.黏多糖贮积症 II 型患者接受酶替代治疗后神经退行性变的血浆生物标志物的改变。
Cell Biochem Biophys. 2023 Sep;81(3):533-542. doi: 10.1007/s12013-023-01149-w. Epub 2023 Jul 20.
7
A glycomic workflow for LC-MS/MS analysis of urine glycosaminoglycan biomarkers in mucopolysaccharidoses.用于黏多糖贮积症尿液糖胺聚糖生物标志物的 LC-MS/MS 分析的糖组学工作流程。
Glycoconj J. 2023 Oct;40(5):523-540. doi: 10.1007/s10719-023-10128-5. Epub 2023 Jul 18.
8
Sanfilippo syndrome: consensus guidelines for clinical care.黏多糖贮积症 Sanfilippo 综合征:临床护理共识指南。
Orphanet J Rare Dis. 2022 Oct 27;17(1):391. doi: 10.1186/s13023-022-02484-6.
9
Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation.基于白消安的清髓性预处理联合经人类基因组编辑的造血干细胞可提高植入率及治疗效果。
Mol Ther Methods Clin Dev. 2022 Apr 19;25:392-409. doi: 10.1016/j.omtm.2022.04.009. eCollection 2022 Jun 9.
10
Mucopolysaccharidosis III: Molecular basis and treatment.黏多糖贮积症 III 型:分子基础与治疗。
Pediatr Endocrinol Diabetes Metab. 2021;27(3):201-208. doi: 10.5114/pedm.2021.109270.